Welcome to LookChem.com Sign In|Join Free
  • or
CYCLOHEXANECARBONITRILE, 4-[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]is a complex chemical compound characterized by a cyclohexane ring with a carbonitrile group and a t-butyl diphenylsilyloxy group. This unique structure makes it a valuable intermediate in the synthesis of organic and pharmaceutical compounds, particularly due to its ability to protect and deprotect hydroxyl groups in organic synthesis.

141336-97-2

Post Buying Request

141336-97-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

141336-97-2 Usage

Uses

Used in Organic Synthesis:
CYCLOHEXANECARBONITRILE, 4-[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]is used as a versatile intermediate for the synthesis of various organic compounds. Its t-butyl diphenylsilyloxy group provides a convenient means for the protection and deprotection of hydroxyl groups, facilitating complex organic reactions and improving the yield of desired products.
Used in Pharmaceutical Compounds:
In the pharmaceutical industry, CYCLOHEXANECARBONITRILE, 4-[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]serves as a key building block for the development of new drugs. Its unique structure and reactivity make it suitable for the synthesis of bioactive molecules with potential therapeutic applications.
Used in Materials Science:
CYCLOHEXANECARBONITRILE, 4-[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]may also find applications in the field of materials science. Its cyclohexane ring and functional groups could be utilized in the design and synthesis of novel materials with specific properties, such as polymers, coatings, or adhesives.
Used in Drug Development:
The potential applications of CYCLOHEXANECARBONITRILE, 4-[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]in drug development are vast. Its unique structure and reactivity make it a promising candidate for the synthesis of new pharmaceutical compounds with improved efficacy, selectivity, and safety profiles. Researchers can leverage its properties to develop innovative drugs for the treatment of various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 141336-97-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,1,3,3 and 6 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 141336-97:
(8*1)+(7*4)+(6*1)+(5*3)+(4*3)+(3*6)+(2*9)+(1*7)=112
112 % 10 = 2
So 141336-97-2 is a valid CAS Registry Number.
InChI:InChI=1/C23H29NOSi/c1-23(2,3)26(21-10-6-4-7-11-21,22-12-8-5-9-13-22)25-20-16-14-19(18-24)15-17-20/h4-13,19-20H,14-17H2,1-3H3

141336-97-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(tert-Butyldiphenylsilyloxy)cyclohexanecarbonitrile

1.2 Other means of identification

Product number -
Other names 4-[tert-butyl(diphenyl)silyl]oxycyclohexane-1-carbonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:141336-97-2 SDS

141336-97-2Downstream Products

141336-97-2Relevant academic research and scientific papers

Novel aminopyridine derivatives having aurora a selective inhibitory action

-

Page/Page column 62-63, (2008/06/13)

The present invention relates to a compound of formula I: wherein: R1 is a hydrogen atom, F, CN, etc.; R1′ is a hydrogen atom or lower alkyl which may be substituted; R2 is O, S, SO, SO2, etc.; R3 is

Substituted sulfonamides, process of preparation and medicines containing same

-

, (2008/06/13)

The present invention concerns new substituted sulfonamides, and the physiologically acceptable salts possibly in the form of complexes, esters and amides thereof, represented by the formula: STR1

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 141336-97-2